皮质类固醇的使用与癌症末期患者的生存期之间的关系
Hideki Katayama1, Masahiro Tabata1,2, Haruhito Kamei3
1Department of Palliative and Supportive Care, Okayama University Hospital, Okayama city, Japan.
Journal of palliative care
|December 20, 2023
概括
在末期癌症患者中用于缓解症状的皮质类固醇使用没有影响存活率. 这项研究发现,接受皮质类固醇和不接受皮质类固醇的患者之间的生存时间没有显著差异.
科学领域:
- 抚慰性护理是一种缓解性护理.
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 皮质类固醇经常被处方用于终末期癌症患者的症状管理.
- 皮质类固醇对这一群体生存的潜在影响仍然是一个关键的临床问题.
研究的目的:
- 为了研究皮质类固醇治疗对末期癌症患者生存的影响.
- 为了比较接受皮质类固醇治疗以缓解症状的患者和未接受皮质类固醇治疗的患者之间的生存率,根据预后分层.
主要方法:
- 在息治疗单位连续治疗癌症患者的回顾性评估.
- 基于使用息性预后 (PaP) 评分预测的预后患者的分层.
- 皮质类固醇治疗组和对照组之间的生存结果的比较.
主要成果:
- 分析包括204名接受皮质类固醇治疗的患者和139名对照患者.
- 在皮质类固醇治疗组和对照组之间没有观察到统计学上显著的生存差异.
- 无论使用皮质类固醇,生存结果在两组中都保持了可比性.
结论:
- 用于缓解末期癌症患者症状的皮质类固醇似乎不会影响生存时间.
- 这些发现表明,皮质类固醇可以安全地用于症状管理,而不会对预后产生不利影响.
相关概念视频
Cancer Survival Analysis
355
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
355
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
121
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
121
Comparing the Survival Analysis of Two or More Groups
195
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
195
Pulmonary Tuberculosis I
244
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
244
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
COPD: Management Using Bronchodilators and Corticosteroids
213
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
213


